- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/42 - Sulfur atoms
Patent holdings for IPC class C07D 233/42
Total number of patents in this class: 42
10-year publication summary
|
0
|
2
|
2
|
1
|
2
|
4
|
3
|
3
|
1
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Arvinas Operations, Inc. | 214 |
7 |
| Abbvie Inc. | 1785 |
2 |
| AbbVie Deutschland GmbH & Co. KG | 262 |
2 |
| Arkema France | 3895 |
2 |
| Denali Therapeutics Inc. | 229 |
2 |
| Endorecherche, Inc. | 25 |
2 |
| Suzhou Kintor Pharmaceuticals, Inc. | 53 |
2 |
| Petroliam Nasional Berhad | 50 |
2 |
| F. Hoffmann-La Roche AG | 7951 |
1 |
| BASF SE | 20458 |
1 |
| Merck Sharp & Dohme Corp. | 2216 |
1 |
| Allergan, Inc. | 2431 |
1 |
| President and Fellows of Harvard College | 5914 |
1 |
| Ardea Biosciences, Inc. | 76 |
1 |
| BioMarin Pharmaceutical Inc. | 374 |
1 |
| Cymabay Therapeutics, Inc. | 112 |
1 |
| Grünenthal GmbH | 593 |
1 |
| Irm LLC | 183 |
1 |
| Janssen Sciences Ireland UC | 241 |
1 |
| Ranbaxy Laboratories Limited | 352 |
1 |
| Other owners | 9 |